CEDAR KNOLLS, N.J.,
April 4, 2019 /PRNewswire/
-- MYOS RENS Technology Inc. ("MYOS" or "the Company")
(NASDAQ: MYOS), an advanced nutrition company and the owner of
Fortetropin®, a proprietary bioactive composition
derived from fertilized egg yolk that helps build lean muscle,
announced today that it has signed a national
brokerage agreement with National Sales Associates ("NSA"),
which will allow MYOS to sell its NSF "Certified for
Sport®" sports nutrition brand,
Yolked®, along with our pet product MYOS
Canine Muscle Formula® ("MYOS Canine") throughout
its national sales network of eight regional offices with over 160
associates.
National Sales Associates is a sales & marketing
brokerage agency that specializes in Natural, Organic, and
Specialty Products across multiple classes of trade. NSA is a
well-structured and tightly integrated national organization,
comprised of six regional sales organizations staffed with industry
veterans that cover the entire U.S.
Joseph Mannello, Chief Executive
Officer of MYOS, commented, "Expanding our channels of
distribution is crucial to getting this muscle health phenomenon
out to both consumers and canine pet owners on a national level.
This agreement with a national brokerage company specializing in
distributing natural, organic and specialty products is a perfect
fit for our all-natural, high-quality products backed by clinical
studies and research. Together, we are excited about the
opportunity to continue to drive and expand the distribution and
sales of Yolked and MYOS Canine with NSA's extensive customer
base."
"We are happy to have been selected by MYOS to represent a
growing company with a truly exceptional set of brands," stated
Jeremy Cook, Vice President and
General Manager of National Sales Associates. "This new partnership
will allow us to distribute natural and unique products that are
highly complementary to NSA's existing product portfolio and to
respond to our customer's needs for natural innovative solutions in
the muscle health field."
About National Sales Associates, LLC
National
Sales Associates is a coast to coast brokerage firm that
specializes in bringing innovative products to market. They
work with a wide array of retail customers throughout the U.S.
primarily in the Natural, Supermarket, Specialty Gourmet, &
Mass Retail Sales Channels. NSA was originally created by the
integration of 5 regional companies and other industry leaders to
fill a need in the marketplace for an additional national sales
solution that combines a strategic approach to the business along
with focused execution for their clients, of which many are high
growth innovators in their respective categories. These entities
cover the U.S. with the following regional breakdown: Northeast
Corporate Office with Key Administrative Staff, East & Midwest
(& Puerto Rico), Rocky
Mountain & Southwest, Southern
California, Northern
California, and the Pacific Northwest. For more information,
please visit www.nationalsalesllc.com.
About Yolked®
Yolked is an NSF Certified
for Sport® all-natural sports nutrition product designed
to work in conjunction with your protein of choice and helps your
body utilize that protein more efficiently. Its key ingredient
Fortetropin, is made through a patented process that maintains the
vital nutrients of fertilized egg yolks to help build more lean
muscle and decrease muscle loss. For more information, please
visit www.yolked.com.
About MYOS Canine Muscle Formula®
MYOS
Canine Muscle Formula is an advanced veterinary health supplement
to support muscle health in dogs, featuring Fortetropin as the
active ingredient. Its key ingredient Fortetropin, is made through
a patented process that maintains the vital nutrients of fertilized
egg yolks to help build more lean muscle and decrease muscle
loss. For more information, please visit www.myospet.com.
About MYOS RENS Technology Inc.
MYOS RENS
Technology Inc. (MYOS), "The Muscle Company®", is a
Cedar Knolls, NJ-based advanced
nutrition company that develops and markets products that improve
muscle health and performance. MYOS is the owner of
Fortetropin®, a fertilized egg yolk-based product
manufactured via a proprietary process to retain and optimize its
biological activity. Fortetropin has been clinically shown to
increase muscle size and lean body mass in conjunction with
resistance training. MYOS believes Fortetropin has the potential to
redefine existing standards of physical health and wellness. For
more information, please visit www.MYOSRENS.com.
Forward-Looking Statements
Any statements in
this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the success of our products,
including Qurr®,
Yolked®, MYOS Enteral
Nutrition Formula™ and MYOS Canine Muscle
Formula® products, the success of our
research and development, the results of the clinical evaluation
of Fortetropin® and its effects, the ability
to enter into new partnership opportunities and the success of our
existing partnerships, the ability to generate revenue and cash
flow from sales of our products, the ability to increase our
revenue and gross profit margins, the ability to achieve a
sustainable, profitable business, the effect of economic
conditions, the ability to protect our intellectual property
rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock Market,
risks in product development, our ability to raise capital to fund
continuing operations, and other factors discussed from time to
time in our filings with the Securities and Exchange
Commission. We undertake no obligation to update or revise any
forward-looking statement for events or circumstances after the
date on which such statement is made except as required by
law.
These statements have not been evaluated by the Food and Drug
Administration. Our products are not intended to diagnose, treat,
cure or prevent any disease.
Investor Relations:
Porter LeVay & Rose
Michael Porter, President
Phone: 212-564-4700
Email: MYOS@plrinvest.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/myos-rens-technology-signs-distribution-agreement-with-national-sales-associates-llc-300824210.html
SOURCE MYOS RENS Technology Inc.